Metabolic Targets in Nonalcoholic Fatty Liver Disease.

Esler, William P; Bence, Kendra K

Esler, William P; Bence, Kendra K.

Affiliation

Esler WP; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, Massachusetts.
Bence KK; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, Massachusetts. Electronic address: kendrakathleen.bence@pfizer.com.

Cell Mol Gastroenterol Hepatol ; 8(2): 247-267, 2019.

Article in En | MEDLINE | ID: mdl-31004828

Subject(s)

Non-alcoholic Fatty Liver Disease/metabolism; Animals; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease/drug therapy; Non-alcoholic Fatty Liver Disease/etiology; Obesity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Type of study: Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Cell Mol Gastroenterol Hepatol Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google